FISCAL 2001 OXIGENE 10-K

Company

Oncotelic Therapeutics, Inc.

Filed

March 29, 2002

Period of Report

December 31, 2001

Accession Number

0000908259-02-000004

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →